Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
71.2M
-
Shares change
-
-784K
-
Total reported value, excl. options
-
$2.47B
-
Value change
-
-$31.5M
-
Put/Call ratio
-
4.22
-
Number of buys
-
82
-
Number of sells
-
-104
-
Price
-
$34.71
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q1 2021
243 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q1 2021.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.2M shares
of 101M outstanding shares and own 70.65% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (11.8M shares), VANGUARD GROUP INC (7.79M shares), BlackRock Inc. (7.63M shares), FMR LLC (5.72M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (3.96M shares), JANUS HENDERSON GROUP PLC (3.28M shares), STATE STREET CORP (3.02M shares), Bank of New York Mellon Corp (2.33M shares), JPMORGAN CHASE & CO (2.18M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.9M shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.